Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in MDD: Sleep EEG and Melatonin
NCT04013464Completed
- Sponsor
- Peking University Sixth Hospital
- Start
- May 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
01
Overview
Open-label trial of escitalopram in major depressive disorder (MDD), sponsored by Peking University Sixth Hospital. Primary endpoints: Hamilton Rating Scale for Depression 17-items at 8 weeks and Montgomery-Asberg Depression Rating Scale at 8 weeks. Started May 2016; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04013464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04013464.